InMed Prognostics

About:

InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuro radiologists, neuro physicians and psychiatrists.

Website: http://www.in-medprognostics.com

Twitter/X: neuro_shield

Top Investors: RICH Research and Innovation Circle of Hyderabad, Biotechnology Industry Research Assistance Council(BIRAC), Exxora, India EdisonTM Accelerator

Description:

InMed Prognostics offers an AI and machine learning (ML)-based MRI tool to neuroradiologists, neuro physicians, and psychiatrists. Its flagship product Neuroshield integrates MRI images, clinical reports, and psychological assessments to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders.

Total Funding Amount:

$2.2M

Headquarters Location:

Pune, Maharashtra, India

Founded Date:

2018-01-01

Contact Email:

contact(AT)in-medprognostics.com

Founders:

Rajesh Kumar Purushottam

Number of Employees:

11-50

Last Funding Date:

2022-12-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai